Gây tê tủy nội tủy: hướng dẫn toàn diện

Intrapulpal Anesthesia: A Comprehensive Clinical and Pharmacological Review 1.0 Executive Summary: The Last Resort Intrapulpal Anesthesia (IPA) is a specialized, supplemental anesthetic technique employed in endodontics primarily for the management of the "hot tooth". It is universally regarded as a technique of last resort, to be used only after conventional nerve blocks and other supplemental injections have failed to achieve profound pulpal anesthesia. It is often described by clinicians as a "blessing in disguise" , capable of providing immediate, profound anesthesia in otherwise unmanageable situations, yet it is a "blessing" that comes "at a price". The mechanism of action for IPA is unique and fundamentally different from other anesthetic techniques. Its success is overwhelmingly attributed to the mechanical generation of back-pressure, which rapidly elevates intrapulpal pressure beyond the neural depolarization threshold, rendering the nerves unresponsive. This pressure-based mechanism is so dominant that studies have confirmed anesthesia can be successfully induced using any liquid, including normal saline, provided it is injected under sufficient pressure. The clinical role of IPA is narrow and specific. It is indicated for the 5 to 10% of patients, typically with symptomatic irreversible pulpitis (SIP) in mandibular molars, who continue to experience pain even after multiple anesthetic attempts, including primary blocks and supplemental intraligamentary (PDL) or intraosseous (IO) injections. This report provides an exhaustive, evidence-based synthesis of the neurophysiology, clinical protocol, comparative efficacy, and critical complications of IPA. It moves beyond simple procedural description to analyze the profound risks associated with the technique. These risks include the "major drawback" of inducing moderate to severe, albeit transient, pain during the injection itself. Furthermore, IPA is critically contraindicated in cases of partial or total pulp necrosis, as the injection pressure risks the iatrogenic apical extrusion of septic debris, which can evoke a severe periapical inflammatory reaction. Finally, this review details a frequently overlooked but severe iatrogenic complication: the chemical interaction between common amide local anesthetics (e.g., lidocaine) and sodium hypochlorite (NaOCl), which forms a toxic, carcinogenic precipitate (2,6-xylidine) that compromises the entire endodontic procedure. 2.0 The Clinical Conundrum: Understanding Anesthetic Failure in the "Hot Tooth" The necessity for a technique as invasive as intrapulpal anesthesia stems directly from the profound failure rate of conventional local anesthesia in endodontics, particularly in the presence of acute pulpal inflammation. 2.1 The Scope of the Problem A "hot tooth" refers to a pulp diagnosed with symptomatic irreversible pulpitis (SIP), characterized by spontaneous, moderate-to-severe pain. While the inferior alveolar nerve block (IANB) is the standard technique for anesthetizing mandibular posterior teeth , its efficacy in patients with SIP plummets. Clinicians and patients alike are familiar with the scenario: the patient reports complete and profound lip and tongue numbness, yet experiences sharp pain upon dental instrumentation. Research quantifies this clinical frustration. While IANB success in uninflamed pulps is high, studies demonstrate that in mandibular molars with SIP, the success rate for achieving pulpal anesthesia drops to a dismal 25% to 48%. This high failure rate creates a stressful and embarrassing situation for the dentist and a traumatic experience for the patient, eroding cooperation and trust. 2.2 Etiologies of Anesthetic Failure (Physiological and Pharmacological) The failure to anesthetize a "hot tooth" is often misattributed to poor operator technique (i.e., a "missed block"). However, the evidence strongly indicates that failure is a pharmacological and physiological event occurring at the level of the inflamed tissue, independent of injection accuracy. The fact that pulpal anesthesia fails even in the presence of 100% lip numbness confirms that the anesthetic successfully reached the nerve trunk, but was unable to anesthetize the specific fibers from the inflamed tooth. This localized failure is multifactorial:

2.2.1 The Inflammatory Milieu (pH Theory) Inflamed tissues, including the dental pulp, exhibit a decreased pH (acidosis) as a byproduct of the inflammatory process. Local anesthetics are weak bases (pKa 7.5-8.9) packaged as acidic salts for stability. To be effective, they must be buffered by the tissue's normal pH ({\approx}7.4) to deprotonate into their lipid-soluble base form, which is the only form that can penetrate the nerve sheath (epineurium). In the acidic environment of an inflamed pulp, the anesthetic solution remains in its ionized, cation form, which is water-soluble. This ionized form cannot cross the lipid nerve membrane, resulting in insufficient intra-neural concentrations of the anesthetic and, consequently, failed anesthesia.
2.2.2 Altered Neurophysiology Inflamed nerves are not physiologically normal. Nociceptors (pain-sensing nerves) in the pulp become sensitized by a "soup" of inflammatory mediators, such as prostaglandins and leukotrienes, released during the inflammatory conversion of arachidonic acid. This process alters their resting potential and significantly reduces their excitability threshold, making them hyperalgesic. These "sensitized" nerves require a much higher concentration of local anesthetic to prevent depolarization.
2.2.3 Sodium Channel Upregulation (The TTX-r Phenomenon) This is a critical molecular mechanism of failure. Inflamed pulpal nociceptors (specifically A-delta and C-fibers ) demonstrate an increased expression and upregulation of specific voltage-gated sodium channel isoforms. Crucially, this includes an increase in Tetrodotoxin-Resistant (TTX-r) channels, such as Na_v 1[span_60](start_span)[span_60](end_span).7, Na_v 1.8, and Na_v 1.9. These specific TTX-r channels are known to be less susceptible to blockade by standard local anesthetics like lidocaine. Therefore, even if the anesthetic successfully penetrates the nerve sheath, it may be pharmacologically incapable of blocking the specific channels that are actively transmitting the pain signal.
2.2.4 Central Sensitization Persistent, intense nociceptive input from the inflamed pulp can alter synaptic processing within the central nervous system (CNS), a phenomenon known as central sensitization. In this state, the CNS amplifies incoming signals, and the patient's perception of pain is exaggerated. This means that even a partially successful block, which might normally be sufficient, is perceived by the patient as total failure.
2.2.5 Anatomical and Psychological Factors While the physiological factors are dominant, anatomical variations, such as accessory innervation to mandibular molars that are not blocked by a standard IANB, can contribute to failure. Furthermore, patient apprehension and anxiety, which are high in SIP cases, are known to reduce pain thresholds and decrease anesthetic efficacy.

These factors converge to create a local, hostile environment within the pulp that is pharmacologically resistant to an anesthetic agent delivered remotely. This understanding provides the fundamental scientific rationale for why localized, supplemental techniques (PDL, IO, and ultimately IPA) are not just "adjuncts" but are, in fact, the only scientifically logical solution to bypass this peripheral resistance. 3.0 Intrapulpal Anesthesia: Definition, Indications, and Critical Contraindications 3.1 Definition Intrapulpal Anesthesia (IPA) is a supplemental anesthetic technique that involves the direct injection of a solution into the pulp chamber or, in multi-rooted teeth, the root canal orifice of a vital tooth. The defining characteristic of IPA is that its efficacy is not passive. It is entirely dependent on the solution being administered under significant pressure. This is achieved by creating a tight seal between the injection needle and the walls of the access cavity or canal orifice, thereby generating "back-pressure". 3.2 Indications The clinical indication for IPA is narrow, specific, and hierarchical. It is explicitly and universally regarded as a "last resort" technique. IPA is indicated only after a clear hierarchy of anesthetic failure has been established: 1. A primary block (e.g., IANB) or infiltration has failed to provide profound pulpal anesthesia. 2. Subsequent, less-invasive supplemental techniques, such as intraligamentary (PDL) or intraosseous (IO) injections, have also failed. 3. The clinician has proceeded with cavity preparation, achieved a pulp exposure, but the patient still experiences moderate to severe pain upon instrumentation of the vital pulp tissue. This scenario is estimated to occur in approximately 5 to 10% of all patients, with a higher prevalence in mandibular molars diagnosed with symptomatic irreversible pulpitis. 3.3 Critical Contraindications and Limitations While effective, IPA is not a panacea and carries significant, absolute contraindications. 3.3.1 Pulp Necrosis (Partial or Total) IPA is strictly contraindicated in any tooth with partial or total pulp necrosis. The technique is only recommended for teeth with vital pulps. This contraindication is the single most critical, high-risk factor in the application of IPA. The technique's mechanism relies on injecting fluid under high pressure into an enclosed space. In a vital pulp, this pressure is contained and acts upon the pulpal nerves. However, in a necrotic or partially necrotic pulp, the system is no longer contained; it is a contaminated space with an apical exit. Injecting under high pressure in this scenario guarantees the iatrogenic apical extrusion of the anesthetic solution, along with "necrotic debris, and pulp tissue". This act is a direct hydraulic inoculation of the periapical tissues with septic material, which will "evoke an inflammatory reaction" and create an acute apical periodontitis or abscess. This transforms a pulpal problem into a severe, iatrogenic periapical problem, leading to extreme post-operative pain and likely treatment failure. Given that traditional diagnostic methods like thermal and electric pulp tests are unreliable in teeth with symptomatic irreversible pulpitis , the clinician faces a diagnostic dilemma. The most reliable clinical indicator to differentiate a vital pulpitis from partial necrosis at the time of injection is the nature of the pulpal bleeding upon exposure. Vital pulp tissue will exhibit brisk, bright red (arterial) bleeding. A lack of bleeding, or the presence of only purulent or dark, venous exudate, indicates pulp necrosis. Therefore, the observation of brisk, vital bleeding from the exposure site is an absolute prerequisite for proceeding with an intrapulpal injection. If necrosis is suspected, a topical anesthetic may be passively applied, but never injected under pressure. 3.3.2 Physical and Anatomical Limitations The technique is contraindicated or will fail if back-pressure cannot be achieved. This includes:

Large Exposures: Large carious lesions or wide access openings that make a "snug needle fit" impossible, as the solution will simply leak back coronally.
Canal Calcification: Significant pulp chamber or canal calcification that prevents the needle from being wedged firmly into an orifice.
Uncontrollable Bleeding: Severe, uncontrollable hemorrhage that prevents visualization of the canal orifice and seating of the needle.

4.0 The Mechanism of Action: A Biomechanical and Pharmacological Synthesis 4.1 The Central Debate The precise mechanism by which IPA achieves its rapid and profound effect has been a subject of discussion, with two primary mechanisms proposed: direct pharmacological nerve inhibition and mechanical pressure-induced anesthesia. 4.2 The Pressure Dominance Theory The overwhelming consensus in the endodontic and anesthetic literature is that the mechanical effect of pressure is the primary, if not sole, factor responsible for the success of IPA. The theory posits that the forced injection of fluid into the rigid, non-compliant pulp chamber causes a rapid and dramatic rise in intrapulpal pressure. This pressure spike rapidly exceeds the depolarization threshold of the pulpal nerves, causing them to fire once (perceived by the patient as a brief, sharp "jolt" ) and then become mechanically unresponsive to further stimuli. It is hypothesized that this continuous pressure may even result in the temporary degeneration of nerve fibers. The clinical evidence for this theory is robust: 1. Back-Pressure is Key: The "most significant factor contributing to the success" of IPA is achieving "strong back-pressure" or "significant resistance" during administration. 2. Passive Deposition Fails: Simply depositing anesthetic passively into the pulp chamber, without pressure, is not adequate and will not result in anesthesia, as the solution will not diffuse throughout the pulp. 3. The "Saline Study": The most compelling evidence comes from a classic double-blind clinical study by Birchfield and Rosenberg. This study compared the efficacy of 2% lidocaine with 1:100,000 epinephrine against normal saline for intrapulpal injections, with both administered under back-pressure. The results were conclusive: 33 of the 35 injections were effective. The data indicated that "an effective intrapulpal injection depends on back-pressure and is independent of the solution used". This finding has been corroborated by other sources, confirming that the anesthetic effect is primarily due to pressure. 4.3 The Pharmacological Contribution While pressure accounts for the onset of anesthesia, a secondary (or concurrent) mechanism involves the classic pharmacological action of the local anesthetic agent. By being deposited directly into the target tissue, the anesthetic solution (e.g., lidocaine, articaine) can bypass the pH-inactivation issues present in the peripheral tissues and achieve a high concentration at the nerve-fiber level. The anesthetic molecules can then directly bind to sodium channels within the nerve membranes, inhibiting the nerve impulse and contributing to the anesthetic state. 4.4 A Biphasic Model: Reconciling the Pressure Paradox A sophisticated, unified understanding of the mechanism requires reconciling two seemingly contradictory facts: 1. The IPA mechanism requires a massive increase in intrapulpal pressure. 2. The most common solutions used contain epinephrine, a vasoconstrictor that is known to cause a significant drop in intrapulpal pressure by reducing pulpal blood flow. This apparent paradox suggests that the mechanism of IPA is not a single event but a biphasic (two-phase) process:

Phase 1: Mechanical Anesthesia (Onset: 0-5 seconds) This phase is the act of injection itself. The clinician is injecting 0.2-0.3 mL of fluid into a rigid, enclosed chamber. This hydraulic force creates a massive, transient, and supra-physiological pressure spike. This pressure spike mechanically deforms the nerve fibers, causing the brief, sharp pain (the "jolt") followed by immediate depolarization failure and profound anesthesia. This phase is entirely solution-independent, which is why saline works in the Birchfield & Rosenberg study.
Phase 2: Pharmacological Anesthesia (Duration: 1-20 minutes) After the injection stops, the hydraulic pressure equalizes. The purely mechanical anesthesia from Phase 1 would be extremely transient (seconds to minutes). However, the pulp chamber is now flooded with a high concentration of local anesthetic and vasoconstrictor. This pharmacological component takes over to provide the duration of anesthesia. The anesthetic agent (e.g., lidocaine) provides a chemical block on the now-accessible nerve endings. Simultaneously, the vasoconstrictor (epinephrine) induces intense local vasoconstriction , which severely reduces pulpal blood flow. This reduced blood flow (a) prevents the rapid washout of the anesthetic agent, holding it at the site of action, and (b) may itself contribute an analgesic effect by inhibiting pulpal nociceptors.

This biphasic model synthesizes all the available data. The onset of IPA is mechanical and pressure-dependent. The duration of IPA (the clinically useful 15-20 minutes ) is pharmacological and solution-dependent. This explains why clinicians must use back-pressure (for onset) but should use an anesthetic-vasoconstrictor solution (for duration). 5.0 A Procedural and Patient Management Protocol Mastery of intrapulpal anesthesia requires equal attention to patient psychology, armamentarium selection, and technical execution. 5.1 Patient Communication: The Non-Negotiable Prerequisite The "major drawback" of IPA is the iatrogenic pain it causes. This is not a "risk" but a "certainty" of the procedure. Therefore, the most critical-non-technical step is patient communication. The clinician must "always warn the patient" before the injection. The patient should be educated about the failure of the previous anesthetic attempts and informed that this final technique will provide the profound anesthesia needed, but that it involves "two sharp sensations" or a "brief period of pain" that will last "only a second or two". This communication manages expectations, establishes consent, and frames the momentary discomfort as a necessary step toward profound pain relief. Failure to provide this warning can be traumatic for the patient, destroying rapport and resulting in "decreased confidence in the endodontist and increased apprehension". 5.2 Armamentarium

Syringe: A standard, conventional dental syringe is all that is required. IPA does not necessitate special pressure syringes, unlike some intraligamentary techniques.
Needle Gauge: A 25-, 27-, 30-, or 31-gauge needle can be used. As discussed in section 5.4.2, evidence strongly favors the use of thinner needles (31-gauge) to reduce injection pain.
Needle Bending: Unlike almost all other injection techniques where needle bending is contraindicated, it is an acceptable and often necessary modification for IPA to allow the clinician to gain direct access to the pulp chamber or canal orifice.

5.3 Step-by-Step Clinical Technique 1. Isolation: The tooth must be isolated, typically with a rubber dam, to ensure an aseptic field and clear visibility. 2. Pulp Exposure: Access the pulp chamber. The ideal exposure for IPA is a small opening, just large enough to admit the needle. This small opening is essential to create a "snug fit" or "wedged" needle. This seal is the key to generating back-pressure. If the exposure is too large (e.g., from extensive caries or over-preparation), back-pressure will be lost as the solution escapes coronally, and the technique will fail. 3. Mitigate Injection Pain: (See section 5.4). Apply a topical anesthetic gel, preferably combined with hyaluronidase, directly to the exposed, bleeding pulp tissue and rub for 1 minute. 4. Needle Insertion: Inform the patient ("you will feel that sharp pinch now"). Insert the (bent) 31-gauge needle into the small exposure site. "Wedge the needle firmly" into the pulp chamber. In a multi-rooted tooth, the needle should be advanced directly into the largest or most sensitive canal orifice until resistance is felt. 5. Injection: Deposit approximately 0.2 to 0.3 mL of anesthetic solution slowly but forcefully, ensuring the injection is under pressure. The clinician must feel "significant resistance" to the injection. The patient will feel a "brief period of pain" as the pressure spikes (Phase 1). After injecting, hold the needle in place for an additional 3 to 5 seconds to ensure pressure is maintained. 6. Onset: Anesthesia onset is "immediate". Instrumentation may begin approximately 30 seconds after the injection. 5.4 Evidence-Based Strategies to Reduce IPA Injection Pain While the claim that IPA "requires no special armamentarium" is technically true for the syringe, an evidence-based, patient-centric approach demands specific adjunctive steps and armamentarium choices to mitigate the technique's primary, "severely painful" drawback.

5.4.1 Topical Anesthesia on the Exposed Pulp A key, evidence-based step to reduce the pain of needle insertion is the application of a topical anesthetic gel directly to the exposed pulp. A 20% benzocaine gel or a lidocaine-prilocaine mixture should be applied to the bleeding pulp exposure and "rubbed for approximately 1 min" to allow penetration and anesthetize the most superficial nerve endings.
5.4.2 The Hyaluronidase Adjunct Clinical trials have demonstrated that the efficacy of this topical application can be significantly enhanced by combining the anesthetic gel (e.g., 20% benzocaine) with hyaluronidase. Hyaluronidase is an enzyme that hydrolyzes hyaluronic acid, a main component of the pulpal connective tissue. This action promotes better diffusion and deeper penetration of the topical anesthetic into the superficial pulpal tissue, resulting in a statistically significant reduction in pain perceived during the subsequent intrapulpal needle insertion.
5.4.3 Needle Gauge Selection Needle choice is not trivial. Randomized clinical trials have demonstrated that thinner needles (i.e., higher gauge) significantly reduce the pain perceived during the intrapulpal injection. A 31-gauge needle is preferred over 27-gauge or 30-gauge needles, as it causes less trauma upon insertion and may create less interstitial pressure during deposition. One study found that the combination of a 31-gauge needle with a topical anesthetic was the most effective pairing for reducing injection pain.

5.5 Table 1: Evidence-Based Strategies for Mitigating Iatrogenic Pain During Intrapulpal Injection Strategy Mechanism of Pain Reduction Key Evidence Clinical Recommendation Patient Communication (Psychological) Manages patient anxiety, eliminates surprise, and reframes the pain as a brief, necessary step. Manages expectations ; prevents loss of confidence. Mandatory first step. "Always warn the patient…". Needle Gauge (31g) (Physical) Smaller diameter needle (31g) causes less tissue trauma and pain upon insertion than larger gauges (27g, 30g). 31g needles "significantly reduce pain". Use a 31-gauge needle as the default for all intrapulpal injections. Topical Anesthetic (on exposed pulp) (Pharmacological) Anesthetizes the superficial nerve endings at the needle insertion site. Apply gel and rub for {\approx}1 min to let it penetrate. Apply 20% benzocaine or lidocaine-prilocaine gel directly to the vital pulp. Topical + Hyaluronidase Adjunct (Pharmacological) Hyaluronidase, an enzyme, breaks down pulpal connective tissue , enhancing diffusion/penetration of the topical anesthetic. "Statistically significant difference" in pain perception. Combine topical gel with hyaluronidase for maximal superficial anesthesia. 6.0 Critical Appraisal: Balancing Profound Efficacy with Profound Risk The decision to employ IPA requires a sober balancing of its significant advantages against its equally significant, multifaceted risks. 6.1 Advantages

Immediate Onset: The most celebrated advantage. Anesthesia onset is "immediate". This provides rapid, definitive relief for both the patient and the clinician, breaking the cycle of failed anesthesia.
High Success Rate & Profundity: When administered correctly (i.e., with back-pressure), the anesthesia achieved is "profound". It "works well" and is highly successful in situations where all other methods have failed.
Simple Armamentarium: The technique does not require expensive, specialized syringes, perforators, or computer-controlled delivery systems , making it universally accessible (unlike intraosseous systems ).
Negligible Systemic Effects: The volume of anesthetic solution used is minimal (typically 0.2-0.3 mL). This tiny dose results in "non-existent or negligible" systemic effects, such as cardiovascular changes.

6.2 Disadvantages and Limitations

Severe Injection Pain: This is the "major drawback". The injection itself, involving needle placement directly into a vital, hypersensitive pulp , is described as "moderately to severely painful". It is the "price" paid for success.
Brief Duration: The anesthesia, while profound, is "short," lasting only 15 to 20 minutes.
Pulp Exposure Required: This is a significant logistical limitation. The technique cannot be used prior to pulp exposure. This means it cannot help manage the pain of cavity preparation or access, which is often when anesthetic failure is first discovered.
Psychological Impact: The pain of the injection, even if successful, can be a traumatic event for the patient. A case report published in the Journal of Endodontics by Miles, a dentally trained neurophysiologist who required endodontic treatment and received an IPA, described the "intense pain" of the injection. He stated that while successful, it resulted in "decreased confidence in the endodontist and increased apprehension".

6.3 The Clinical Practice Cascade of Short Duration The 15- to 20-minute duration of anesthesia is not just a simple limitation; it creates a high-pressure "clinical practice cascade" that can negatively impact the quality of the endodontic procedure. This "short duration" requires that the "bulk of the pulpal tissue must be removed quickly". This places the clinician in a "race against the clock." This rush to perform a pulpectomy or pulpotomy before the anesthesia wears off increases the risk of procedural errors, such as inefficient tissue removal, ledging, or missing a vital, still-sensitive canal. If the clinician is not fast enough, or if the case presents with complex anatomy (e.g., calcified canals ), the anesthesia will wear off mid-procedure. The patient will suddenly experience a return of sharp pain. This re-creates the initial problem, but in a significantly worse clinical context: the patient is now highly apprehensive , has a rubber dam in place, and has lost all faith in the clinician's ability to manage their pain. This acute limitation on working time contrasts sharply with the more controlled, 60-minute duration afforded by a successful intraosseous injection. 7.0 IPA in the Hierarchy of Supplemental Anesthesia 7.1 The Need for a Hierarchy Given the high, predictable failure rate of the IANB in SIP cases , a structured, evidence-based hierarchy of supplemental techniques is a clinical necessity. The primary supplemental (or "spongy" ) techniques available to the clinician after a failed IANB are the Intraligamentary (PDL) injection, the Intraosseous (IO) injection, and the Intrapulpal (IPA) injection. 7.2 Comparative Efficacy

Intraligamentary (PDL) Injection:
Efficacy: Success rates after IANB failure are variable, reported in a range from 48% to 74%.
Re-injection: Success can be increased to over 90% with a second PDL injection.
Pros: Can be performed with a standard syringe (though pressure syringes exist) , rapid onset.
Cons: Very short duration , risk of bacteremia (contraindicated in at-risk patients) , and can cause significant post-operative soreness or a "high" feeling on the tooth.
Intraosseous (IO) Injection (e.g., Stabident, X-Tip):
Efficacy: This is the most effective supplemental technique available. Success rates after IANB failure are consistently high, at approximately 80% to 98%.
Superiority: IO injection has been shown to be significantly more effective than PDL injection.
Pros: Immediate onset , good, reliable duration of up to 60 minutes.
Cons: Requires special armamentarium (a specialized drill/perforator). It also causes a transient, significant, and predictable increase in heart rate (tachycardia) due to the rapid systemic uptake of the vasoconstrictor.
Intrapulpal (IPA) Injection:
Efficacy: High success, if back-pressure is achieved.
Pros: Immediate onset , no special syringe needed.
Cons: Extremely painful injection , very short duration (15-20 min) , and requires pulp exposure (cannot be used pre-access).

7.3 The "Practice vs. Evidence" Hierarchy The comparative efficacy data defines a very clear, evidence-based hierarchy for managing a failed IANB in a "hot tooth": 1. First Choice Supplemental (Pre-exposure): Intraosseous (IO) Injection. It has the highest success rate (80-98%) , is more effective than PDL , and provides a long, 60-minute working time. 2. Second Choice Supplemental (Pre-exposure): Intraligamentary (PDL) Injection. Less effective on the first attempt (48-74%) , but success improves with re-injection. 2. Last Resort (Post-exposure): Intrapulpal (IPA) Injection. To be used only when both IO and PDL have failed and the pulp has been exposed, but remains sensitive. However, the research reveals a significant and concerning contradiction between this evidence-based hierarchy and the self-reported hierarchy of common clinical practice. A survey of general practitioners and specialists (BDS and MDS graduates) on their management of "hot tooth" situations found :

The most common supplementary injection used was Intrapulpal Anesthesia (IPA).
The least preferred and most underutilized technique was the Intraosseous (IO) technique (reported use by only 6.8% of clinicians).

This is a major "knowledge-translation" failure. The data shows that clinicians are widely underutilizing the most effective supplemental technique (IO), likely due to barriers in cost, training, and the perceived complexity of the special armamentarium. Instead, they are defaulting to the "last resort" technique (IPA) as their primary supplement. This common practice pattern exposes patients to an unnecessarily painful injection , the high-pressure "race against the clock" , and the significant chemical risks (detailed in Section 8.0) that are all associated with IPA. 7.4 Table 2: Comparative Analysis of Supplemental Anesthetic Techniques for the 'Hot Tooth' (After IANB Failure) Technique Primary Mechanism Required Armamentarium Onset Duration Success Rate Key Advantages Key Disadvantages Intraosseous (IO) Deposition of anesthetic directly into cancellous bone. Specialized perforator system (e.g., Stabident, X-Tip). Immediate {\approx}60 minutes 80-98% Highest success rate; Long working time; Can be used pre-exposure. Requires special kit ; Causes tachycardia ; Cost. Intraligamentary (PDL) Deposition of anesthetic into the PDL space. Standard or Pressure Syringe. Rapid Short ({\approx}30-45 min) 48-74% (Improves to {>}90\% w/ re-injection) No special kit needed ; Avoids collateral soft tissue numbness. Short duration; Post-op soreness ; Bacteremia risk. Intrapulpal (IPA) Mechanical pressure spike in the pulp chamber. Standard Syringe. Immediate Very Short (15-20 min) High (if back-pressure is achieved) Immediate/profound effect ; No special kit needed. Extremely painful injection ; Requires pulp exposure ; Very short duration. 8.0 The Critical, Overlooked Complication: Iatrogenic Chemical Interactions Beyond the well-documented risks of injection pain and apical extrusion, a critical, high-risk complication of IPA occurs after the injection: the chemical interaction between the local anesthetic solution and endodontic irrigants. 8.1 The Clinical Scenario After a successful (but painful) IPA, the clinician has achieved profound anesthesia. The immediate next step in the endodontic workflow is to control hemorrhage and begin pulpal extirpation and canal debridement. The agent used for this is, almost universally, Sodium Hypochlorite (NaOCl). The pulp chamber, still containing residual local anesthetic from the injection, is then flooded with NaOCl. 8.2 The Chemical Interaction (Lidocaine + NaOCl) This seemingly routine and benign sequence harbors a significant, iatrogenic chemical complication. A "careful review of literature" reveals that lidocaine hydrochloride (both with and without adrenaline) chemically interacts with Sodium Hypochlorite.

Precipitate Formation: This interaction immediately forms a "white precipitate" that subsequently changes color to "reddish brown".
The Precipitate: Nuclear Magnetic Resonance (NMR) spectroscopy has analyzed and identified this precipitate as 2,6-xylidine.
Toxicity: 2,6-xylidine is not an inert substance. It is a known toxic compound and a known carcinogen.

8.3 Clinical Consequences of the Precipitate This iatrogenic precipitate creates two simultaneous, devastating consequences that compromise the entire endodontic procedure, one chemical and one mechanical. 8.3.1 Chemical Consequence: Compromised Disinfection The chemical reaction that forms the 2,6-xylidine precipitate consumes the Free Active Chlorine (FAC) in the NaOCl solution. The FAC (in the form of hypochlorous acid and hypochlorite ions) is the active ingredient solely responsible for NaOCl's potent antibacterial and tissue-dissolving properties. Studies show a "significant reduction" in the FAC of NaOCl when admixed with lidocaine, even in small proportions. This means the clinician, believing they are irrigating with a potent 3% or 5.25% NaOCl solution, is actually irrigating with a chemically neutralized and ineffective solution. This "unseen" failure of disinfection can directly lead to long-term microbiological failure of the root canal treatment. 8.3.2 Mechanical Consequence: Compromised Obturation The 2,6-xylidine precipitate is an insoluble solid. In vitro studies using scanning electron microscopy (SEM) have shown that this precipitate occludes the dentinal tubules at all levels of the root canal (coronal, middle, and apical). Worse, this precipitate cannot be completely removed, even with subsequent chemo-mechanical preparation and irrigation protocols. This iatrogenic blockage of the dentinal tubules directly interferes with sealer penetration. Studies have confirmed that sealer penetration (for both epoxy resin and calcium silicate-based sealers) is "significantly" reduced in the presence of the 2,6-xylidine precipitate. This compromises the three-dimensional hermetic seal (obturation) of the root canal system, leading to long-term microleakage and mechanical failure. This creates a devastating iatrogenic cycle: the technique used to solve the immediate problem (pain) directly causes the long-term failure (poor disinfection and poor sealing) of the endodontic treatment. 8.4 Anesthetic Agent Alternatives

Articaine: Studies investigating the interaction between 4% articaine and NaOCl found that it also forms a precipitate. However, it is a different precipitate (identified as MAMC) which is "reported to exhibit the least toxicity". While less toxic, the problem of a physical precipitate that can occlude tubules remains.
Mepivacaine: Studies comparing mepivacaine and lidocaine for pulpectomy pain have shown mepivacaine may offer higher success. 3% Mepivacaine plain (without a vasoconstrictor) is a common choice for IO injections in cardiac-compromised patients and is a viable option for IPA, relying solely on the pressure mechanism. Its interaction with NaOCl is less documented in the provided materials, but as an amide anesthetic, an interaction is possible.

8.5 The Mandatory Clinical Protocol: The "Saline Flush" This entire iatrogenic cycle is 100% preventable with one simple, additional step. After administering IPA (with any amide anesthetic) and achieving profound anesthesia, the pulp chamber must be "thoroughly irrigated" or "flushed" with an inert solution before the introduction of NaOCl. The Protocol: Use 0.9% Normal Saline or sterile water to copiously flush the pulp chamber and canal orifices, removing all residual local anesthetic solution. Only after this "Saline Flush" is it safe to introduce NaOCl for hemostasis, tissue dissolution, and disinfection. This "Saline Flush" is not optional; it is a mandatory, critical step in the IPA protocol to prevent chemical inactivation of irrigants and mechanical blockage of the dentinal tubules. 9.0 Concluding Synopsis and Future Directions 9.1 Synopsis This report has critically synthesized the evidence on Intrapulpal Anesthesia, revealing it as a technique defined by paradox.

It is both an "ultimate weapon" and a "blessing" for endodontists, yet it is simultaneously "moderately to severely painful" and can "decrease confidence" in the operator.
Its mechanism of onset is purely mechanical pressure , yet its duration is pharmacological (the Biphasic Model).
It is the most commonly used supplemental technique in general practice , yet it should be the absolute last choice in the evidence-based hierarchy (the Practice vs. Evidence Gap).
Its application to solve the immediate problem of acute pain can, if used incorrectly, directly cause the long-term endodontic failure of the tooth through overlooked iatrogenic chemical interactions (the Iatrogenic Cycle).

9.2 The Clinician's Final Mandate The use of Intrapulpal Anesthesia requires a mastery of four distinct and equally important procedures: 1. Mastery of the Hierarchy: Knowing when not to use it. This means attempting the superiorly effective Intraosseous (IO) injection as the primary supplement before pulp exposure. 2. Mastery of Patient Communication: Ethically and effectively managing the patient's expectation and experience of the iatrogenic pain. 3. Mastery of the Technique: Executing the injection with the correct armamentarium (31-gauge needle , topical/hyaluronidase adjunct ) and the correct mechanics (small exposure, "snug fit," and generation of back-pressure ). 4. Mastery of Chemical Safety: Performing the mandatory post-injection "Saline Flush" to prevent the catastrophic interaction with NaOCl. 9.3 Future Research Directions Future research must focus on mitigating the significant drawbacks of IPA.

Pain Reduction: The most pressing need is to reduce the pain of the injection itself. This includes further research into:
Advanced topical formulations combining anesthetics with penetration enhancers like hyaluronidase.
The use of adjunctive cryotherapy (e.g., application of Endo-Ice) to the exposed pulp prior to needle insertion.
Chemical Compatibility: Research is urgently needed to identify:
Anesthetic agents or formulations that provide effective anesthesia but do not form toxic, occluding precipitates with NaOCl.
Alternative, non-reacting flushing or hemostatic agents (e.g., chitosan ) that can be safely used after IPA instead of NaOCl.
Knowledge Translation: The significant "practice vs. evidence" gap demonstrates a critical need for better education and training on the superior efficacy and safety of Intraosseous (IO) anesthesia. The goal should be to reduce the clinical need for IPA from "5-10% of cases" to as close to zero as possible.

Works cited 1. Intrapulpal anesthesia in endodontics: an updated literature review – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC11304041/ 2. Local Anesthetics in Oakdale & Seven Fields, PA | Dentists Near Me – Advanced Dentistry, https://www.advanceddentistry412.com/sedation-dentistry/local-anesthetic/ 3. INTRAPULPAL INJECTION, https://www.aae.org/specialty/wp-content/uploads/sites/2/2017/07/winter2009bonusmaterialg.pdf 4. Pain Perception during Intrapulpal Anesthesia: A Systematic Literature Review, https://www.johcd.net/abstractArticleContentBrowse/JOHCD/33551/JPJ/fullText 5. Pain Perception during Intrapulpal Anesthesia: A Systematic Literature Review – Journal of Oral Health and Community Dentistry, https://www.johcd.net/doi/10.5005/jp-journals-10062-0168 6. Intrapulpal Anesthesia – EndoExperience, https://endoexperience.com/opinions/endodontic-therapy/intrapulpal-anesthesia/ 7. Clinical Considerations of Intrapulpal Anesthesia in Pediatric Dentistry – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC5341638/ 8. Intrapulpal injection: factors related to effectiveness – PubMed, https://pubmed.ncbi.nlm.nih.gov/9007921/ 9. Local Anesthesia Techniques in Dentistry and Oral Surgery – StatPearls – NCBI Bookshelf, https://www.ncbi.nlm.nih.gov/books/NBK580480/ 10. Successful Local Anesthesia: What Endodontists Need to Know, https://www.aae.org/specialty/successful-local-anesthesia-what-endodontists-need-to-know/ 11. Supplemental pulpal anesthesia for mandibular teeth – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC3722689/ 12. Pain management during endodontic treatment of mandibular posterior teeth: a narrative review – Journal of Oral and Maxillofacial Anesthesia, https://joma.amegroups.org/article/view/6672/html 13. Efficient removal of 2,6-xylidine precipitate using different agitation protocols: An in vitro field emission scanning electron microscopic study – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC9089760/ 14. Interaction between lidocaine hydrochloride (with and without adrenaline) and various irrigants: A nuclear magnetic resonance analysis – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC4119375/ 15. Management Protocols of the Hot Tooth—A KAP Survey among General Dentists and Endodontists – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC10466530/ 16. Effective Strategies to Manage the Clinically Challenging Hot Tooth: A Review, https://www.jodend.com/doi/10.5005/jp-journals-10047-0128 17. Anesthetic Efficacy in Irreversible Pulpitis: A Randomized Clinical Trial – SciELO, https://www.scielo.br/j/bdj/a/9Ky8wMYJ43s7m8J7DY6cFjP/?lang=en 18. Local Anesthesia in Challenging Situations – Root Canal Specialty Associates, https://rootcanaldocs.com/articles/local-anesthesia-in-challenging-situations/ 19. Needle Gauge Influences Pain Perception During Intrapulpal Anaesthesia – JournalAgent, https://jag.journalagent.com/eurendodj/pdfs/EEJ_5_3_191_198.pdf 20. Classification of local anesthesia methods – OAText, https://www.oatext.com/Classification-of-local-anesthesia-methods.php/1000 21. Local anesthetic failure in endodontics:, https://bestendoglenview.com/wp-content/uploads/2022/07/Local-anesthetic-failure-in-Enododontics-Mechanisms-and-Management.pdf 22. The clinical significance of intrapulpal anesthesia for painless dental procedure – SciSpace, https://scispace.com/pdf/the-clinical-significance-of-intrapulpal-anesthesia-for-5d4f3vit6t.pdf 23. Irreversible pulpitis and achieving profound anesthesia: Complexities and managements – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC4767074/ 24. (PDF) Hot tooth -A challenge to endodontists – ResearchGate, https://www.researchgate.net/publication/338935822_Hot_tooth_-A_challenge_to_endodontists 25. Anaesthetic failure in irreversible pulpitis: strategies for the general dental practitioner, https://the-probe.co.uk/blog/2025/11/anaesthetic-failure-in-irreversible-pulpitis-strategies-for-the-general-dental-practitioner/ 26. ENDODONTICS – American Association of Endodontists, https://www.aae.org/uploadedfiles/publications_and_research/endodontics_colleagues_for_excellence_newsletter/winter09ecfe.pdf 27. Supplemental Anesthetic Techniques for Symptomatic Irreversible Pulpitis – Inside Dentistry, https://insidedentistry.net/2020/04/supplemental-anesthetic-techniques-for-symptomatic-irreversible-pulpitis/ 28. Supplemental Injection Techniques, http://www.columbia.edu/itc/hs/dental/d6401/2007/supplementalBW.pdf 29. (PDF) Intrapulpal anesthesia in endodontics: an updated literature review – ResearchGate, https://www.researchgate.net/publication/382817230_Intrapulpal_anesthesia_in_endodontics_an_updated_literature_review 30. Various Strategies for Pain-Free Root Canal Treatment – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC3881296/ 31. Iatrogenic Damage to the Periodontium Caused by Endodontic Treatment Procedures: An Overview – The Open Dentistry Journal, https://opendentistryjournal.com/VOLUME/9/PAGE/214/FULLTEXT/ 32. Apical extrusion of debris: a literature review of an inherent occurrence during root canal treatment – PubMed, https://pubmed.ncbi.nlm.nih.gov/23711187/ 33. Cytokines as Diagnostic Biomarkers for Pulpitis: Exploring Their Role in Vital Pulp Therapy, https://www.aae.org/specialty/cytokines-as-diagnostic-biomarkers-for-pulpitis-exploring-their-role-in-vital-pulp-therapy/ 34. Comparative Outcomes of Pulpotomy in Mature Molars with Irreversible Pulpitis: A Non-Randomized Trial Evaluating Calcified and Non-Calcified Pulp Chambers – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC10787182/ 35. Clinical and radiographic evaluation of pulpotomies performed with intrapulpal anesthesia | Request PDF – ResearchGate, https://www.researchgate.net/publication/11790401_Clinical_and_radiographic_evaluation_of_pulpotomies_performed_with_intrapulpal_anesthesia 36. The effect of epinephrine on pulpal microcirculation – PubMed, https://pubmed.ncbi.nlm.nih.gov/229139/ 37. Effects of Local Anesthetics With Vasoconstrictors on Dental Pulp Blood Flow and Oxygen Tension – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC8674846/ 38. Effect of local anesthesia on pulpal blood flow in mechanically stimulated teeth – Semantic Scholar, https://pdfs.semanticscholar.org/6d2d/1a89eee72f13555680c8dfec4934e077e4fb.pdf 39. Pharmacological Interactions of Epinephrine at Concentrations Used in Dental Anesthesiology: An Updated Narrative Review – MDPI, https://www.mdpi.com/2571-841X/8/4/224 40. COHEN'S PATHWAYS of the PULP, https://amu.edu.az/storage/files/22/D%C9%99rslikl%C9%99r/Cohens-Pathways-of-the-Pulp-11e_1.pdf 41. The inner and outer diameter of 31-gauge needle – ResearchGate, https://www.researchgate.net/figure/The-inner-and-outer-diameter-of-31-gauge-needle_fig2_341388240 42. Needle Gauge Influences Pain Perception During Intrapulpal Anaesthesia – A Randomized Clinical Trial – PubMed, https://pubmed.ncbi.nlm.nih.gov/33353913/ 43. Needles – Local Anesthesia in Pediatric Dentistry – Dentalcare.com, https://www.dentalcare.com/en-us/ce-courses/ce325/needles 44. How to Anesthetize hot tooth – YouTube, https://www.youtube.com/watch?v=eXwaajdfayY 45. Anaesthetic Efficacy of Topical Benzocaine Gel Combined with Hyaluronidase for Supplemental Intrapulpal Injection in Teeth with Irreversible Pulpitis- A Double Blinded Clinical Trial – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC4576652/ 46. [PDF] Anaesthetic Efficacy of Topical Benzocaine Gel Combined with Hyaluronidase for Supplemental Intrapulpal Injection in Teeth with Irreversible Pulpitis- A Double Blinded Clinical Trial. | Semantic Scholar, https://www.semanticscholar.org/paper/Anaesthetic-Efficacy-of-Topical-Benzocaine-Gel-with-Sooraparaju-Abarajithan/11df8b7ff2813b22d8f561be753e8ce62f6bbb5d 47. (PDF) Anaesthetic Efficacy of Topical Benzocaine Gel Combined with Hyaluronidase for Supplemental Intrapulpal Injection in Teeth with Irreversible Pulpitis- A Double Blinded Clinical Trial – ResearchGate, https://www.researchgate.net/publication/282608363_Anaesthetic_Efficacy_of_Topical_Benzocaine_Gel_Combined_with_Hyaluronidase_for_Supplemental_Intrapulpal_Injection_in_Teeth_with_Irreversible_Pulpitis-_A_Double_Blinded_Clinical_Trial 48. (PDF) Needle Gauge Influences Pain Perception During Intrapulpal Anaesthesia – A Randomized Clinical Trial – ResearchGate, https://www.researchgate.net/publication/341388240_Needle_Gauge_Influences_Pain_Perception_During_Intrapulpal_Anaesthesia_-_A_Randomized_Clinical_Trial 49. Adjuncts to Local Anesthesia: Separating Fact from Fiction – Canadian Dental Association, https://www.cda-adc.ca/jcda/vol-67/issue-7/391.html 50. Efficacy of Combined Versus Supplementary Injection Techniques With Inferior Alveolar Nerve Block for Mandibular Molars With Symptomatic Irreversible Pulpitis: A Systematic Review and Network Meta‐Analysis, https://pmc.ncbi.nlm.nih.gov/articles/PMC12518700/ 51. Anesthetic efficacy of supplemental intraligamentary injection in human mandibular teeth with irreversible pulpitis: a systematic review and meta-analysis – Semantic Scholar, https://pdfs.semanticscholar.org/ac19/4da1756c76711e7f284052e78ba5c75f3182.pdf 52. Anesthetic efficacy of supplemental intraligamentary injection in human mandibular teeth with irreversible pulpitis: a systematic review and meta-analysis – PubMed, https://pubmed.ncbi.nlm.nih.gov/35169615/ 53. Anesthetic success of supplemental infiltration in mandibular molars with irreversible pulpitis: A systematic review – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC4450520/ 54. SUPPLEMENTAL INJECTIONS, https://www.aae.org/specialty/wp-content/uploads/sites/2/2017/07/winter2009bonusmateriale.pdf 55. Local Anesthesia Strategies for the Patient With a “Hot” Tooth | Pocket Dentistry, https://pocketdentistry.com/local-anesthesia-strategies-for-the-patient-with-a-hot-tooth/ 56. Alternative techniques for failure of conventional inferior alveolar nerve block – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC6620537/ 57. Comparison of the anaesthetic efficacy of and heart rate changes after periodontal ligament or intraosseous X-Tip injection in mandibular molars: a randomized controlled clinical trial – PubMed, https://pubmed.ncbi.nlm.nih.gov/22506833/ 58. Comparison of two intraosseous anesthetic techniques in mandibular posterior teeth | Request PDF – ResearchGate, https://www.researchgate.net/publication/8969439_Comparison_of_two_intraosseous_anesthetic_techniques_in_mandibular_posterior_teeth 59. Influence of Lignocaine Hydrochloride with Adrenaline on Free Active Chlorine Content of Sodium Hypochlorite Solution Admixed in Various Proportions – JournalAgent, https://jag.journalagent.com/eurendodj/pdfs/EEJ_6_1_117_121.pdf 60. Interaction between lidocaine hydrochloride (with and without adrenaline) and various irrigants – Semantic Scholar, https://pdfs.semanticscholar.org/72ef/3b0c8ffb74ea880aadaec485ac951c57d14a.pdf 61. Influence of Lignocaine Hydrochloride with Adrenaline on Free Active Chlorine Content of Sodium Hypochlorite Solution Admixed in Various Proportions – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC8056803/ 62. International Journal of Dental Science and Innovative Research (IJDSIR), https://www.ijdsir.com/asset/images/uploads/16740586249513.pdf 63. ARTICLE – Dialnet, https://dialnet.unirioja.es/descarga/articulo/8822800.pdf 64. Intrapulpal injection, Precipitation, Push out bond strength, Sealer – JCDR, https://www.jcdr.net/article_fulltext.asp?issn=0973-709x&year=2020&month=July&volume=14&issue=7&page=ZC14&id=13835 65. Evaluation of 2,6‑xylidine precipitate on sealer penetration of calcium silicate‑based sealer and resin‑based sealer: An i – Ovid, https://www.ovid.com/journals/eddt/pdf/10.4103/endo.endo_167_24~evaluation-of-26-xylidine-precipitate-on-sealer-penetration 66. A spectroscopic assessment of interaction between 4% articaine hydrochloride with adrenaline and various endodontic irrigants – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC7737823/ 67. A spectroscopic assessment of interaction between 4% articaine hydrochloride with adrenaline and various endodontic irrigants – PubMed, https://pubmed.ncbi.nlm.nih.gov/33343842/ 68. Comparison of the Anesthetic Efficacy of Mepivacaine and Lidocaine in Patients with Irreversible Pulpitis: A Double-blind Randomized Clinical Trial – PubMed, https://pubmed.ncbi.nlm.nih.gov/27475099/ 69. Comparative evaluation of 2% mepivacaine and 2% lidocaine for inferior alveolar nerve block: a double-blind randomized clinical trial – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC12584461/ 70. Efficacy and safety of mepivacaine compared with lidocaine in local anaesthesia in dentistry: a meta-analysis of randomised controlled trials – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC9376404/

⚠️ Thông tin kỹ thuật: Nội dung trong bài viết này chỉ mang tính chất tham khảo kỹ thuật dành cho chuyên gia nha khoa. Việc lắp đặt và sử dụng thiết bị y tế phải tuân thủ đúng hướng dẫn của nhà sản xuất và thực hiện bởi nhân viên được đào tạo. Liên hệ ANH & EM để được hỗ trợ kỹ thuật cụ thể.